S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Jul 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Advanced breast cancer; Cancer metastases; Lung cancer; Multiple myeloma; Prostate cancer; Solid tumours
- Focus Adverse reactions
- 12 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2018.
- 12 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2018.
- 04 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Jul 2017.